Taiwan is in talks to buy vaccines that offer crossover protection against monkeypox, as well as antiviral medications that could be used to treat patients who develop a severe reaction to the disease, the Centers for Disease Control (CDC) said Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in MPOX
-
![Taiwan CDC raises travel alert for 7 African countries due to mpox]()
Taiwan CDC raises travel alert for 7 African countries due to mpoxTaiwan's Centers for Disease Control (CDC) raised its travel alert for the Democratic Republic of the Congo (DRC) and six other African countries on Thursday after the World Health Organization (WHO) declared the mpox outbreak in Africa as a public health emergency of international concern (PHEIC).08/15/2024 07:02 PM -
![Taiwan reports 1st mpox death]()
Taiwan reports 1st mpox deathTaiwan on Tuesday reported the nation's first death from mpox involving a Taiwanese man in his 30s, according to the Centers for Disease Control (CDC).11/07/2023 07:26 PM -
![Taiwan adds China, Thailand to travel alert list amid growing mpox cases]()
Taiwan adds China, Thailand to travel alert list amid growing mpox casesThe Taiwan Centers for Disease Control (CDC) on Tuesday raised a travel notice relating to mpox (monkeypox) for China and Thailand following surges in cases of the disease there, advising people to practice precaution when traveling to the two countries.08/15/2023 10:05 PM
Latest
-
Cross-Strait
Venezuela, Iran moves boost U.S. ahead of Trump-Xi talks: Scholars
03/09/2026 06:34 PM -
Culture
MOFA closes Taiwan Review, to shut Taiwan Today in late 2026
03/09/2026 05:26 PM -
Business
Taiwan's natural gas supply sufficient through April, minister says
03/09/2026 04:57 PM -
Politics
Taichung mayor to embark on 11-day U.S. visit Wednesday to boost ties
03/09/2026 04:46 PM -
Business
Taiex posts 4th largest fall as Middle East war causes oil price spike
03/09/2026 04:22 PM